The role of the gut microbiota in NAFLD

被引:712
|
作者
Leung, Christopher [1 ,2 ]
Rivera, Leni [3 ,4 ]
Furness, John B. [4 ]
Angus, Peter W. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Austin Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic 3084, Australia
[3] Deakin Univ, Sch Med, Metabol Res Unit, Geelong, Vic 3216, Australia
[4] Univ Melbourne, Dept Anat & Neurosci, Grattan St, Parkville, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
FATTY LIVER-DISEASE; GLYCATION END-PRODUCTS; OBSTRUCTIVE SLEEP-APNEA; DE-NOVO LIPOGENESIS; INCREASED INTESTINAL PERMEABILITY; DIET-INDUCED OBESITY; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; ARTIFICIAL SWEETENERS; OBETICHOLIC ACID;
D O I
10.1038/nrgastro.2016.85
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
NAFLD is now the most common cause of liver disease in Western countries. This Review explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut health. Animal studies in which the gut microbiota are manipulated, and observational studies in patients with NAFLD, have provided considerable evidence that dysbiosis contributes to the pathogenesis of NAFLD. Dysbiosis increases gut permeability to bacterial products and increases hepatic exposure to injurious substances that increase hepatic inflammation and fibrosis. Dysbiosis, combined with poor diet, also changes luminal metabolism of food substrates, such as increased production of certain short-chain fatty acids and alcohol, and depletion of choline. Changes to the microbiome can also cause dysmotility, gut inflammation and other immunological changes in the gut that might contribute to liver injury. Evidence also suggests that certain food components and lifestyle factors, which are known to influence the severity of NAFLD, do so at least in part by changing the gut microbiota. Improved methods of analysis of the gut microbiome, and greater understanding of interactions between dysbiosis, diet, environmental factors and their effects on the gut-liver axis should improve the treatment of this common liver disease and its associated disorders.
引用
收藏
页码:412 / 425
页数:14
相关论文
共 50 条
  • [1] Role of the gut microbiota in NAFLD
    Gerard, P.
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2022, 26 (03): : 98 - 117
  • [2] The role of the gut microbiota in NAFLD
    Christopher Leung
    Leni Rivera
    John B. Furness
    Peter W. Angus
    [J]. Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 412 - 425
  • [3] Role of gut microbiota: Obesity and NAFLD
    Gangarapu, Venkatanarayana
    Yildiz, Kemal
    Ince, Ali Tuzun
    Baysal, Birol
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02): : 133 - 140
  • [4] Role and effective therapeutic target of gut microbiota in NAFLD/NASH
    Liu, Qun
    Liu, Shousheng
    Chen, Lizhen
    Zhao, Zhenzhen
    Du, Shuixian
    Dong, Quanjiang
    Xin, Yongning
    Xuan, Shiying
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 1935 - 1944
  • [5] Gut Microbiota and Lifestyle Interventions in NAFLD
    Houghton, David
    Stewart, Christopher J.
    Day, Christopher P.
    Trenell, Michael
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04)
  • [6] Crosstalk between PPARs and gut microbiota in NAFLD
    Wu, Liwei
    Li, Jingjing
    Feng, Jiao
    Ji, Jie
    Yu, Qiang
    Li, Yan
    Zheng, Yuanyuan
    Dai, Weiqi
    Wu, Jianye
    Guo, Chuanyong
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 136
  • [7] Gut Microbiota: Association with NAFLD and Metabolic Disturbances
    Lau, E.
    Carvalho, D.
    Freitas, P.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [8] Gut microbiota produce alcohol and contribute to NAFLD
    Zhu, Lixin
    Baker, Robert D.
    Zhu, Ruixin
    Baker, Susan S.
    [J]. GUT, 2016, 65 (07) : 1232 - 1232
  • [9] Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
    Jiang, Xiaofan
    Zheng, Juan
    Zhang, Shixiu
    Wang, Baozhen
    Wu, Chaodong
    Guo, Xin
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [10] Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
    Hrncir, Tomas
    Hrncirova, Lucia
    Kverka, Miloslav
    Hromadka, Robert
    Machova, Vladimira
    Trckova, Eva
    Kostovcikova, Klara
    Kralickova, Pavlina
    Krejsek, Jan
    Tlaskalova-Hogenova, Helena
    [J]. MICROORGANISMS, 2021, 9 (05)